ONYDA XR

Growth

clonidine hydrochloride

NDAORALSUSPENSION, EXTENDED RELEASE
Approved
May 2024
Lifecycle
Growth
Competitive Pressure
0/100

Mechanism of Action

2 -adrenergic receptors in the brain. Clonidine is not a central nervous system stimulant. The mechanism of action of clonidine in ADHD is not known.

Indications (3)

Attention Deficit Hyperactivity Disorder (ADHD)adjunctive therapy to central nervous system (CNS) stimulant medications in pediatric patients 6 years of ageolder

Loss of Exclusivity

LOE Date
Jul 28, 2041
187 months away
Patent Expiry
Jul 28, 2041

Patent Records (2)

Patent #ExpiryTypeUse Code
8062667
Mar 29, 2029
Product
—
11918689
Jul 28, 2041
Product
U-3944
External Resources
DailyMed
Full prescribing information
FDA Drugs@FDA
FDA approval history
RxNorm
Drug nomenclature & identifiers